Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 7;3(4):e238.
doi: 10.1212/NXI.0000000000000238. eCollection 2016 Aug.

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination

Andrea Cortese  1 , Jérôme J Devaux  1 , Elisabetta Zardini  1 , Constance Manso  1 , Guillaume Taieb  1 , Clarisse Carra Dallière  1 , Philippe Merle  1 , Cecilia Osera  1 , Silvia Romagnolo  1 , Nicolò Visigalli  1 , Giuseppe Piscosquito  1 , Ettore Salsano  1 , Enrico Alfonsi  1 , Arrigo Moglia  1 , Davide Pareyson  1 , Enrico Marchioni  1 , Diego Franciotta  1
Affiliations

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination

Andrea Cortese et al. Neurol Neuroimmunol Neuroinflamm. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Absence of anti–neurofascin-155 (NF155) antibodies in combined central and peripheral demyelination (CCPD)
(A) Clinical features of the patients with CCPD. EMRN = encephalomyeloradiculoneuritis; IVIG = IV immunoglobulin; MRN = myeloradiculoneuritis; PNS = peripheral nervous system. (B–E) Serum samples from patients with CCPD (n = 16), patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) (n = 26), patients with other peripheral neuropathy (PN) (n = 15), patients with multiple sclerosis (MS) (n = 15), and healthy controls (HC) (n = 20) were tested for autoantibodies to rat NF155 (B) and human NF155 (C) by ELISA. Optical densities (OD) to NF155 are shown after subtraction of baseline OD reading to bovine serum albumin. The cutoff (red line) represents the mean of HC and other PN groups plus 3 standard deviations. (D) Serum from NF155-positive patients with CIDP, but not sera of patients with CCPD, reacted against myc-tagged human NF155 in HEK293 cells. (E) NF155-positive CIDP serum, but not sera of patients with CCPD, colocalized with contactin-1, an axonal protein that interacts with glial NF155 at paranodes, in mouse sciatic nerve fibers. Scale bars (D, E): 10 μm.
See this image and copyright information in PMC

References

    1. Kamm C, Zettl UK. Autoimmune disorders affecting both the central and peripheral nervous system. Autoimmun Rev 2012;11:196–202. - PubMed
    1. Marchioni E, Ravaglia S, Montomoli C, et al. . Postinfectious neurologic syndromes: a prospective cohort study. Neurology 2013;80:882–889. - PubMed
    1. Kawamura N, Yamasaki R, Yonekawa T, et al. . Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 2013;81:714–722. - PubMed
    1. Ogata H, Matsuse D, Yamasaki R, et al. . A nationwide survey of combined central and peripheral demyelination in Japan. J Neurol Neurosurg Psychiatry 2016;87:29–36. - PubMed
    1. Ng JK, Malotka J, Kawakami N, et al. . Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology 2012;79:2241–2248. - PMC - PubMed

LinkOut - more resources